Evidence map›Paper›PMID 31456341›Full record

ArticlePhysiological reports2019

Nexrutine

Darpan I Patel, Derek Wallace, Kira Abuchowski, Paul Rivas, Amber Gallegos, Nicolas Musi, Addanki Pratap Kumar

Open access · goldAbstract read
In one paragraph

Article in Physiological reports, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
0.5field-weighted citation impact, top 34% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 5 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. NexrutinePhysiological reports · 2019
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 1 institution in 1 country.

Darpan I PatelSchool of Nursing, University of Texas Health Science Center at San Antonio, San Antonio, Texas.ORCID 0000-0001-8124-8072
Derek WallaceSchool of Nursing, University of Texas Health Science Center at San Antonio, San Antonio, Texas.
Kira AbuchowskiSchool of Nursing, University of Texas Health Science Center at San Antonio, San Antonio, Texas.
Paul RivasDepartment of Urology, School of Medicine, University of Texas Health Science Center at San Antonio, San Antonio, Texas.
Amber GallegosSchool of Nursing, University of Texas Health Science Center at San Antonio, San Antonio, Texas.
Nicolas MusiBarshop Institute for Aging, University of Texas Health Science Center at San Antonio, San Antonio, Texas.
Addanki Pratap KumarMays Cancer Center at UT Health San Antonio, San Antonio, Texas.
The University of Texas Health Science Center at San Antonio · US

Funding

TISSUE CULTURE---COREP30CA054174 · NCI · UNIVERSITY OF TEXAS HLTH SCIENCE CENTER · PI Robin Jean Leach · 1991 to 2026
$59.1M
NIH HHS P30CA054174
6 · The paper itself

Abstract

Muscle loss is a debilitating side effect to prostate cancer (PCa) experienced by nearly 60% of men. The purpose of this study was to test the hypothesis that Nexrutine

Indexed as

AdenocarcinomaAnimalsAtrophyDisease Models, AnimalMaleMiceMice, Inbred C57BLMice, TransgenicMuscle, SkeletalPhysical Conditioning, AnimalPlant ExtractsProstatic NeoplasmsRandom AllocationNexrutinePlant Extractsatrophyinflammationnatural productneoplasm of the prostateproteolysis-inducing factor

Identifiers

PMID31456341
PMCPMC6712237
OpenAlexW2970007337

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.